Skip to main content

Table 1 Laboratory and urinalysis data findings before and after regimen of orally administered vibegron

From: Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report

Laboratory test Before vibegron After vibegron Reference range Units
Results Results
WBC 12.5 6.0 3.3–8.6 × 103/µL
RBC 4.54 4.51 3.86–4.92 × 106/µL
Hb 12.7 12.8 11.6–14.8 g/dL
HCT 37.2 38.4 35.1–44.4 %
PLT 248 328 158–348 × 103/µL
TP 7.3 6.9 6.6–8.1 g/dL
ALB 4.4 4.8 4.1–5.1 g/dL
AST 28 23 13–30 IU/L
ALT 12 13 7–23 IU/L
LDH 228 216 124–222 IU/L
ALP 469 706 106–322 IU/L
CRE 0.34 0.39 0.46–0.79 mg/dL
BUN 8.6 11.1 8–20 mg/dL
UA 6.1 2.9 2.6–5.5 mg/dL
Na 138 138 138–145 mmol/L
K 3.8 4.2 3.6–4.8 mmol/L
CL 100 103 101–108 mmol/L
Ca 9.9 9.6 8.8–10.1 mg/dL
Laboratory test Before vibegron After vibegron Reference range Units
Results Results
Urinalysis
 Color Yellow Yellow Yellow  
 Clarity Cloudy Cloudy Clear  
 Specific gravity 1.017 1.021 1.003–1.030  
 pH 7.5 8.0 4.5–8.0  
 Urobilinogen Normal Normal Normal  
 Bilirubin Negative  
 Leukocytes 3+ 1+ Negative  
 Nitrite + + Negative  
 Blood Negative  
 Protein +− Negative  
 Glucose Negative  
 Ketone Negative  
Urine microscopy
 Red blood cells 5–9 1–4 Negative /hpf
 White blood cells 50–99 10–19 Negative /hpf
 Casts Negative /hpf
 Dysmorphic RBC Negative Negative Negative  
 Epithelial cells Negative Negative Negative /hpf
 Bacteria + + Negative  
Urine culture E. coli E. coli Negative  
  1. Before: while continuing to take propiverine. After: after taking vibegron for a month
  2. ALB albumin, ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate aminotransferase, BUN blood urea nitrogen, Ca calcium, CL chloride, CRE creatinine, Hb hemoglobin, HCT hematocrit, LDH lactate dehydrogenase, K potassium, Na sodium, PLT platelets, RBC red blood cells, TP total protein, UA uric acid, WBC white blood cells